Fish Oil Flops Again in Afib Study

September 30, 2014 3:18 PM

15 0

High-dose fish oil failed to reduce atrial fibrillation (Afib) recurrence in patients with a history of Afib who were not receiving conventional antiarrhythmic therapy, Canadian researchers said.

The AFFORD trial's primary endpoint was the time to first symptomatic or asymptomatic Afib recurrence lasting greater than 30 seconds, and among patients who took 4 g daily of fish oil, the primary endpoint occurred in 64.1%, versus 63.2% of patients in the placebo arm, for a hazard ratio of 1.10 (95...

Read more

To category page